NCT05714397

Effectiveness of Cingal™ for Improving Pain Scores and Function in Anterior Knee Pain

• Status: Not Yet Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 24 (estimated)
• Sponsor: Banff Sport Medicine Foundation · Academic / Other
• Sex: All
• Age: 18 Years – 35 Years
• Healthy volunteers: Not accepted

Summary

Anterior Knee Pain (AKP) is a common condition that can be challenging to treat effectively. The main goal of treatment regimens is to improve the function of the knee. However, treatment can be challenging due to the knee pain experience. Cingal™ contains hyaluronic acid (HA), which acts as a joint lubricant, and the corticosteroid triamcinolone hexacetonide (TH). Some studies have shown that Cingal™ can improve joint function and provide short-term pain relief.

Conditions

• Anterior Knee Pain Syndrome

Interventions

Type	Name	Description
DEVICE	Cingal	A single Cingal injection will be administered by fellowship-trained physicians through ultrasound-guided injection using a 20-gauge needle into the joint space of the knee under sterile conditions. The needle track will be anesthetized with local anesthetic.

Timeline

• Start date: 2026-04-01
• Primary completion: 2026-04-01
• Completion: 2026-11-01
• First posted: 2023-02-06
• Last updated: 2025-02-05

Locations

1 site across 1 country: Canada